(Health-NewsWire.Net, May 17, 2016 ) Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. Inflammation and ulcers are formed in the innermost lining of the colon and rectum, resulting in the production of pus and mucous. Based on the extent of inflammation and the location, ulcerative colitis can be of different types: ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis. Abdominal cramps, diarrhea, and rectal bleeding are among the common symptoms observed in individuals with the disease. Medications such as 5-aminosalicylates, steroids, purine analogs, immunomodulators, and biologics are used to treat the disease.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=717610
Technavios analysts forecast the global ulcerative colitis market to grow at a CAGR of 6.6% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.
The market is divided into the following segments based on geography: Americas APAC EMEA
New report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Browse Detail Report With TOC @ http://www.researchmoz.us/global-ulcerative-colitis-market-2016-2020-report.html
Key vendors AbbVie Janssen Biotech Merck Takeda Pharmaceuticals
Other prominent vendors Abbott Ajinomoto Pharmaceuticals Amgen Arena Pharmaceuticals AstraZeneca Astellas Pharma Avaxia Biologics BioLineRx Celgene Cosmo Pharmaceuticals Eisai Ferring Pharmaceuticals Galapagos Genentech Gilead Sciences GlaxoSmithKline Hutchison Medi Pharma Immune Pharmaceuticals InDex Pharmaceuticals Kaken Pharmaceutical Kissei Pharmaceutical Kyowa Hakko Kirin Lipid Therapeutics Meda Mitsubishi Tanabe Mochida Pharmaceutical Morphotek Nestl Pfizer Procter & Gamble Qu Biologics Receptos Salix Pharmaceuticals Shield Therapeutics Shire Pharmaceuticals Sterna Biologicals Tillotts Pharma TopiVert UCB Zeria Pharmaceutical
Market driver Increase in patient assistance programs For a full, detailed list, view our report
Market challenge Patent expiries For a full, detailed list, view our report
Market trend Rising use of biologics For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|